# Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY)

> Source: Nexqual · https://nexqual.com/RICFY · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY), nexqual.com/RICFY" · informational, not investment advice.

**Price:** USD 14.34 (+15.43% on the day) · last close of Oct 22, 2026; US market closed, not a live price. Prev close 12.42 · day 15.48–15.48 · 52w 9.29–17.16 · market cap $11.9B · PNK

## Key facts
- Analysts: None.
- Total return with dividends: 1Y -0.1% vs S&P 500 +14.4%; 5Y +30.2% vs S&P 500 +77.0%.

## Analysts
Consensus None.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2023-11-27) |
|---|---|---|
| Total return | -0.1% | +30.2% |
| S&P 500 (SPY) | +14.4% | +77.0% |
| Per year | -0.1% | +9.5% |
| Volatility (annualized) | 96.0% | 50.1% |
| Max drawdown | -33.1% (Apr 2026→May 2026) | -33.3% (Jul 2025→May 2026) |

## Peers (Drug Manufacturers - General)
GRFS (Grifols, S.A.) USD 7.54 +1.14% · BIIB (Biogen Inc.) USD 250.38 -1.36% · OGN (Organon & Co.) USD 13.76 +0.07% · SNY (Sanofi) USD 41.51 -1.08% · GSK (GSK plc) USD 50.62 -1.15% · BMY (Bristol-Myers Squibb Company) USD 61.55 -2.31%

## More
Full page: https://nexqual.com/RICFY · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | — | — | — | $674.4M | — |
| Next quarter (ends 2026-12-31) | — | — | — | $684.8M | — |
| Current fiscal year (ends 2026-12-31) | — | — | — | $2.79B | — |
| Next fiscal year (ends 2027-12-31) | — | — | — | $3.03B | — |